Tevogen Bio Holdings Inc.
TVGN
$6.97
-$0.03-0.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.88M | 19.95M | 20.16M | 21.89M | 23.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.14M | 30.89M | 31.25M | 34.40M | 53.56M |
| Operating Income | -26.14M | -30.89M | -31.25M | -34.40M | -53.56M |
| Income Before Tax | -26.28M | -31.04M | -31.20M | -35.36M | -13.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.28 | -31.04 | -31.20 | -35.36 | -13.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.28M | -31.04M | -31.20M | -35.36M | -13.73M |
| EBIT | -26.14M | -30.89M | -31.25M | -34.40M | -53.56M |
| EBITDA | -25.95M | -30.72M | -31.04M | -34.24M | -53.40M |
| EPS Basic | -8.63 | -10.69 | -10.93 | -11.37 | -4.29 |
| Normalized Basic EPS | -5.28 | -6.62 | -6.79 | -7.81 | -12.56 |
| EPS Diluted | -8.87 | -10.94 | -11.18 | -11.65 | -21.16 |
| Normalized Diluted EPS | -5.28 | -6.62 | -6.79 | -7.81 | -12.33 |
| Average Basic Shares Outstanding | 12.89M | 12.97M | 12.45M | 11.85M | 11.37M |
| Average Diluted Shares Outstanding | 12.89M | 12.97M | 12.45M | 11.85M | 11.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |